Atlas Trials

A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer

Clinical trial NCT05999994 · RECRUITING

Trial details

NCT number
NCT05999994
Sponsor
Eli Lilly and Company
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
NeoplasmsChildAdolescent
Start date
2020-01-22
Primary completion
2027-05-01
Enrollment
105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.